1.646.889.1200|info@lifescipublicrelations.com

Reata CEO on positive trial results for drug to treat Friedreich’s ataxia

/, video/Reata CEO on positive trial results for drug to treat Friedreich’s ataxia

Reata CEO on positive trial results for drug to treat Friedreich’s ataxia

Warren Huff, Reata Pharma CEO, joins CNBC’s “Power Lunch” team to discuss his company’s positive clinical trial results for a drug to treat the neuromuscular disease Friedreich’s ataxia.

By | 2019-10-21T13:49:49-04:00 October 18th, 2019|News, video|Comments Off on Reata CEO on positive trial results for drug to treat Friedreich’s ataxia

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.